Skip to content
Screener

Beam Therapeutics BEAM Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$42.79M-3.7%
MGN
MagniteMGNI
6.1%0.0pp
Wave Life Sciences logo
Wave Life SciencesWVE
$39.5M+159%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$85.95M-33.4%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$128.67M-8.3%
Prime Medicine logo
Prime MedicinePRME
$120.47M+0.2%

Other financials

Income statement

See full
Revenue$31.7M+325%
Operating income-$107.2M+10.1%
Net income-$94.3M+12.9%
EPS (diluted)-$0.91+26.0%

Balance sheet

See full
Cash & equivalents$288.3M-45.4%
Total debt$250.8M+58.6%
Total equity$1.2B+3.1%
Total assets$1.5B+0.9%

Cash flow

See full
Operating cash flow-$128.5M-23.7%
CapEx$2.2M-27.2%
Free cash flow-$130.7M-22.2%

Valuation

See full
Market cap$2.81B+52.0%
Enterprise value$2.78B+61.1%
P/S17.2×-13.6×

Profitability

See full
Operating margin-226.6%-90.5pp
Net margin-742.7%
FCF margin-234%-86.6pp

Returns & leverage

See full
Return on equity-47.1%
Debt / equity0.2×+0.1×
Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Beam Therapeutics’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 7:22 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-210338
Line itemMarch 31,2026December 31,2025
Total current assets1,266,9531,268,688
Property and equipment, net101,247104,500
Restricted cash6,6936,676
Operating lease right-of-use assets98,148100,679
Other assets7,757634
Total assets$1,480,798$1,481,177
Liabilities and stockholders’ equity
Current liabilities:

Item 1. Financial Statements (Unaudited)

FAQ

What is Beam Therapeutics's operating lease ROU assets?
Beam Therapeutics (BEAM) reported operating lease ROU assets of $98.15M in Q1 2026.
How has Beam Therapeutics's operating lease ROU assets changed year-over-year?
Beam Therapeutics's operating lease ROU assets decreased by 4.0% year-over-year, from $102.22M to $98.15M.
What is the long-term trend for Beam Therapeutics's operating lease ROU assets?
Over 5 years (2020 to 2025), Beam Therapeutics's operating lease ROU assets has grown at a 3.0% compound annual growth rate (CAGR), from $86.86M to $100.68M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Beam Therapeutics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude